Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors

被引:66
|
作者
Lin, Mong-Wei [1 ]
Chang, Yih-Leong [2 ]
Huang, Pei-Ming [1 ]
Lee, Yung-Chie [1 ]
机构
[1] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10002, Taiwan
[2] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Pathol, Taipei 10002, Taiwan
关键词
Myasthenia gravis; Thymectomy; Video-assisted thoracoscopic surgery; ASSISTED THORACOSCOPIC THYMECTOMY; TRANSSTERNAL THYMECTOMY; AUTOIMMUNE MYASTHENIA; EXTENDED THYMECTOMY; THORACIC-SURGERY; EXPERIENCE; STANDARDS;
D O I
10.1016/j.ejcts.2009.05.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: While thymectomy is an accepted treatment for myasthenia gravis (MG), video-assisted thoracoscopic surgery (VATS) thymectomy has recently become a popular surgical treatment, especially for non-thymomatous MG (NTMG). This study aims to compare the results of VATS thymectomy and trans-sternal thymectomy, and identify prognostic factors in NTMG patients after thymectomy. Methods: A 10-year retrospective review (January 1995 to December 2004) of 60 consecutive thymectomies (22 trans-sternal thymectomies and 38 VATS thymectomies) of NTMG patients performed in a university teaching hospital was undertaken. Results: There were 43 female patients and 17 male patients with a median MG-onset age of 25 years (range: 5-78 years). Median follow-up time was 44 months. VATS thymectomy patients had a shorter hospital stay than the trans-sternal thymectomy patients (5.6 days vs 8.1 days, p = 0.008). There was no other statistically significant difference between the two operative methods in NTMG patients, including intensive care unit (ICU) stay, ventilator support time, operative time, postoperative status, complete stable remission (CSR) rate, morbidity and mortality. Three prognostic factors associated with better remission rate were hyperthyroidism (p = 0.003), age <40 years (p = 0.022) and the presence of thymic hyperplasia (p = 0.041). Other factors, including gender, disease duration, preoperative MG severity, acetylcholine receptor antibody, perioperative therapy and operative methods (32% vs 36%, p = 0.91, 95% confidence interval (CI) = 0.27-3.21) were not statistically relevant to better remission rate. Conclusions: VATS thymectomy is more advantageous for NTMG patients because of shorter hospital stay, less tissue injury, better cosmetic result and equivalent CSR rate. NTMG patients aged <40 years with hyperthyroidism and a histologic diagnosis of lymphofollicular hyperplasia have better chances of remission after thymectomy. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [21] Effect of thymectomy on late onset non-thymomatous myasthenia gravis
    Kawaguchi, N.
    Kuwabara, S.
    Nemoto, Y.
    Fukutake, T.
    Arimura, K.
    Osame, M.
    Hattori, T.
    8TH INTERNATIONAL CONGRESS OF NEUROIMMUNOLOGY, 2006, : 155 - 158
  • [22] Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis
    Kim, Seung Woo
    Choi, Young-Chul
    Kim, Seung Min
    Shim, Hyo Sup
    Shin, Ha Young
    JOURNAL OF NEUROLOGY, 2019, 266 (04) : 960 - 968
  • [23] Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study
    Carolina Barnett
    Hans D Katzberg
    Shaf Keshavjee
    Vera Bril
    Orphanet Journal of Rare Diseases, 9
  • [24] Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis
    Seung Woo Kim
    Young-Chul Choi
    Seung Min Kim
    Hyo Sup Shim
    Ha Young Shin
    Journal of Neurology, 2019, 266 : 960 - 968
  • [25] Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study
    Barnett, Carolina
    Katzberg, Hans D.
    Keshavjee, Shaf
    Bril, Vera
    ORPHANET JOURNAL OF RARE DISEASES, 2014, 9 : 214
  • [26] EFFECT OF THYMECTOMY IN ELDERLY NON-THYMOMATOUS GENERALIZED MYASTHENIA GRAVIS PATIENTS
    Kim, S.
    Choi, Y.
    Kim, S.
    Shin, H.
    MUSCLE & NERVE, 2018, 58 : S111 - S111
  • [27] CURRENT PERSPECTIVES OF NEUROLOGISTS REGARDING APPROACH TO THYMECTOMY IN NON-THYMOMATOUS MYASTHENIA GRAVIS
    McClane, Jenna
    Gaughan, John
    Hunter, Krystal
    Bowen, Frank
    Campellone, Joseph
    MUSCLE & NERVE, 2018, 58 : S43 - S43
  • [28] Prediction of improvement after extended thymectomy in non-thymomatous myasthenia gravis patients
    Yoshida, Mitsuteru
    Kondo, Kazuya
    Matsui, Naoko
    Izumi, Yuishinn
    Bando, Yoshimi
    Yokoishi, Michihiro
    Kajiura, Kouichirou
    Tangoku, Akira
    PLOS ONE, 2020, 15 (10):
  • [29] A crucial first randomized controlled trial of thymectomy in non-thymomatous myasthenia gravis
    Bourque, Pierre R.
    Chardon, Jodi Warman
    JOURNAL OF THORACIC DISEASE, 2016, 8 (10) : E1375 - E1378
  • [30] Thymectomy in Non-thymomatous Myasthenia Gravis: Results from MGTX, a Randomized, Controlled Trial
    Cutter, Gary
    Kaminski, Henry
    Wolfer, Gil
    Aban, Immaculada
    NEUROLOGY, 2016, 86